00 / 00
Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Our cancer risk assessment team of physicians, nurses, and genetic counselors help individuals and families determine their risk of getting cancer through clinical and genetic evaluation and screening.
The team then designates steps to help an individual reduce their cancer risk.
The Risk Assessment Program at Fox Chase Cancer Center is a clinical and research service run by the Department of Clinical Genetics that offers education, screening and counseling to individuals with cancer and those who are at risk of getting cancer.
A leader in cancer prevention and risk assessment, Fox Chase Cancer Center established one of the first risk programs in the country in 1991 for individuals with a family history of breast and/or ovarian cancer. This program served as a model for others around the country and led to risk assessment services at Fox Chase for other types of cancers including prostate, GI and lung cancers, as well as skin cancer. Today, our Department of Clinical Genetics builds on this pioneering spirit to offer the most comprehensive risk assessment program in the Philadelphia region. It encompasses all of Fox Chase’s clinical services for healthy people at risk for cancer, as well as innovative research in the areas of cancer prevention and genetics.
The Risk Assessment team conducts research into how cancer develops, how it can be prevented, and how it can be best treated, with the goal of reducing the risk of cancer for individuals, families, and communities.
If you would like to subscribe to the Prevention Matters newsletter, register here